BRCA1 and ovarian cancer: However, it has to be kept in mind that the TMB in breast and ovarian cancers, even that from BRCA1 germline mutation carriers, is an order of magnitude lower compared to hypermutated cancers such as melanoma and lung cancer (The Cancer Immunome Atlas (TCIA) https://tcia.at/home).